ID

34581

Beschreibung

Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Children With Type 1 Diabetes in a Diabetes Camp; ODM derived from: https://clinicaltrials.gov/show/NCT02189694

Link

https://clinicaltrials.gov/show/NCT02189694

Stichworte

  1. 19.01.19 19.01.19 -
Rechteinhaber

see on clinicaltrials.gov

Hochgeladen am

19. Januar 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Type 1 Diabetes NCT02189694

Eligibility Type 1 Diabetes NCT02189694

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
males or females between the 8 and 17 years of old.
Beschreibung

ID.1

Datentyp

boolean

clinical diagnosis of type 1 diabetes for at least one year. the subject will have been on insulin pump therapy for at least 3 months.
Beschreibung

ID.2

Datentyp

boolean

hba1c ≤ 11.0%.
Beschreibung

ID.3

Datentyp

boolean

Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
clinically significant nephropathy, neuropathy or retinopathy as judged by the investigator.
Beschreibung

ID.4

Datentyp

boolean

severe hypoglycemic episode within two weeks of inclusion in the study. a severe hypoglycemic episode is defined as loss of conscience, seizure or a hospital emergency visit.
Beschreibung

ID.5

Datentyp

boolean

current use of oral glucocorticoid medication (except low stable dose according to investigator judgement). stable doses of inhaled steroids are acceptable.
Beschreibung

ID.6

Datentyp

boolean

known or suspected allergy to the trial products.
Beschreibung

ID.7

Datentyp

boolean

other serious medical illness likely to interfere with study participation or with the ability to complete the trial by the judgment of the investigator.
Beschreibung

ID.8

Datentyp

boolean

failure to comply with team's recommendations (e.g. not willing to use trial pump, etc).
Beschreibung

ID.9

Datentyp

boolean

Ähnliche Modelle

Eligibility Type 1 Diabetes NCT02189694

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
males or females between the 8 and 17 years of old.
boolean
ID.2
Item
clinical diagnosis of type 1 diabetes for at least one year. the subject will have been on insulin pump therapy for at least 3 months.
boolean
ID.3
Item
hba1c ≤ 11.0%.
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
clinically significant nephropathy, neuropathy or retinopathy as judged by the investigator.
boolean
ID.5
Item
severe hypoglycemic episode within two weeks of inclusion in the study. a severe hypoglycemic episode is defined as loss of conscience, seizure or a hospital emergency visit.
boolean
ID.6
Item
current use of oral glucocorticoid medication (except low stable dose according to investigator judgement). stable doses of inhaled steroids are acceptable.
boolean
ID.7
Item
known or suspected allergy to the trial products.
boolean
ID.8
Item
other serious medical illness likely to interfere with study participation or with the ability to complete the trial by the judgment of the investigator.
boolean
ID.9
Item
failure to comply with team's recommendations (e.g. not willing to use trial pump, etc).
boolean

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video